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Abstract: Acrylamide, which forms in heat-treated foods with high carbohydrate content, is a probable
human carcinogen. This study aimed to evaluate the association between dietary acrylamide intake
and lung cancer using data from the Japan Public Health Center based Prospective Study. Our study
included 85,303 participants who completed a food frequency questionnaire. Cox proportional
hazards regression models were used to assess hazard ratios and 95% confidence intervals (CIs)
after adjusting for confounders. After 14.3 years and 15.4 years of mean follow-up period, 1187 and
485 lung cancer cases were identified in men and women, respectively. The multivariable-adjusted
hazard ratios of 10-µg/day increment in acrylamide intake were 1.01 (95% CI, 0.99–1.02) in men
and 0.98 (95% CI, 0.95–1.02) in women. Compared with the lowest quartile of acrylamide intake,
the hazard ratios for the highest quartile were 1.13 (95% CI, 0.95–1.33; p for trend = 0.12) in men and
1.03 (95% CI, 0.78–1.36; p for trend = 0.86) in women in the multivariable-adjusted model. Moreover,
there was also no significant association observed in the stratified analysis for histological subtypes
of lung cancer. This study demonstrated that dietary acrylamide intake was not associated with
increased lung cancer risk in the Japanese population.
Keywords: dietary acrylamide; lung cancer; cohort; Japan
1. Introduction
In 1994, acrylamide, an important industrial chemical, was classified as probably carcinogenic to
humans (Group 2A) by the International Agency for Research on Cancer based on its carcinogenic action
in rodents [1]. Until the early 2000s, the primary sources of acrylamide exposure were considered to be
specific occupations and smoking [2]. Later, Swedish researchers reported that acrylamide is formed by
the Maillard reactions during high-temperature (>120 ◦C) cooking, mainly in carbohydrate-rich foods,
such as French fries and potato crisps, and coffee [3–5], reflecting the importance of meals as another
source of acrylamide [3]. It is thought that the carcinogenic action of dietary acrylamide occurs in a
genotoxic way. Glycidamide, the major metabolite of acrylamide, is able to bind to DNA and cause the
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formation of DNA adducts [6]. Theoretically, all tissues are targets for carcinogenesis since acrylamide
molecules are small and hydrophilic, indicating that it can reach every organ and tissue in the body [7].
Epidemiological studies regarding the relationship between occupational acrylamide exposure
and cancer risk have been previously conducted [8–12], and no positive results were observed. In the
past years, studies on the association between dietary acrylamide intake and risk of cancers were mainly
published in Western countries. According to these studies, positive associations were found only for
kidney cancer [13], endometrial and ovarian cancer [14], and postmenopausal estrogen-receptor-positive
breast cancer [15].
Potato-based foods, wheat-based products, and coffee are the main food sources of dietary
acrylamide in the Western population, while in the Japanese population, the main food sources of
dietary acrylamide are coffee and green tea, followed by confectioneries, vegetables, and potatoes [16].
Consequently, the influence of acrylamide intake on cancers in different countries with diverse
dietary sources of the chemical needs to be investigated. Recently, several Asian studies evaluated
breast, endometrial, ovarian, esophageal, gastric, and colorectal cancer risks in relation to dietary
acrylamide intake [16–18]. The results showed no positive association, which is consistent with those
in Western countries.
To our knowledge, two studies have reported the association between dietary acrylamide exposure
and lung cancer [19,20]. However, epidemiological evidence for lung cancer was evaluated inadequately.
Therefore, the present study aimed to confirm the potential relationship between dietary acrylamide
intake and lung cancer incidence using a Japanese-population-based prospective study.
2. Materials and Methods
2.1. Study Cohorts and Participants
The Japan Public Health Center based Prospective Study (JPHC) started in 1990 (Cohort I) and 1993
(Cohort II). Its design has been described elsewhere [21]. The JPHC study enrolled 140,420 residents aged
40–69 years in 11 public health center areas across Japan in the baseline survey, using a self-administered
lifestyle questionnaire. After 5 years, a follow-up survey including more complete information on
food intake frequency was conducted. We applied this 5-year follow-up survey as the starting point of
our study.
Participants registered in Tokyo had no available information on cancer incidence, and those
registered in Osaka had a different definition of the study population. Therefore, we did not include
the participants in these two areas in the current study. Further, we excluded those who did not meet
the follow-up criteria and those who failed to complete the 5-year follow-up survey questionnaire.
We also excluded participants who died or moved out of the study areas during the time from the
baseline survey to the 5-year follow-up survey, those with past history of any cancer, and those who
were lost to follow-up. Subsequently, participants providing incomplete information on total energy
intake and reporting extremely low or high energy values were also excluded.
All subjects gave their informed consent for inclusion before they participated in the study.
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was
approved by the Institutional Review Board of the National Cancer Center, Japan (Ethical Approval
Code: 2001-021), as well as Osaka University (Ethical Approval Code: 14020-9) and Azabu University
(Ethical Approval Code: 2457).
2.2. Assessment of Acrylamide Intake
The estimation of nutrient and food intake was performed using the Food Frequency Questionnaire
(FFQ). Information on the common consumption of 147 food items over the past years has been
collected [22]. The standard portion sizes were specified in three categories (<0.5 times the standard,
same as the standard, and >1.5 times the standard). There were nine frequency categories of food items
(never, 1–3 times/month, 1–2 times/week, 3–4 times/week, 5–6 times/week, once/day, 2–3 times/day,
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4–6 times/day, and ≥7 times/day). The FFQ was validated by comparison between intake and 28-day
weighted dietary records (DRs) as reference in a subcohort of the JPHC Study [22–24]. Daily nutrient
intake was calculated based on the Fifth Revised and Enlarged Edition of the Standard Tables of Food
Composition in Japan (5th FCT) [25].
An acrylamide database [26], developed from measured values of acrylamide content in common
Japanese foods [27–36], was used to estimate acrylamide intake. There were 1878 food items in
the 5th FCT. Of these, 282 food items were identified as acrylamide-containing foods. Others were
non-acrylamide-containing foods (1276 items) and unclassifiable foods (320 items). Furthermore,
since the acrylamide level in the same food is different because of various cooking methods,
39 heat-treated food items were added to the acrylamide-containing foods. Therefore, 321 food
items (17% of the total food items) were considered acrylamide-containing foods to estimate the
DR-derived acrylamide intake [26]. By linking the measured values of acrylamide content and the list
of foods [27–36], the development of the acrylamide database was completed.
Among the 147 food items of the FFQ, 28 items (19%) were also designated as acrylamide-containing
foods. As mentioned previously, the acrylamide level differs between cooking methods. Because the
amount of raw food intake in the FFQ is usually used to calculate most nutrient intakes, in calculating
the FFQ-derived acrylamide intake, the cooking method for food items listed below needs to be
considered, and the proportion of these heat-treated foods calculated from the DR should be used:
starchy vegetables (potato, sweet potato), vegetables (onion, bean sprouts, sweet pepper, squash,
cabbage, snap beans, broccoli), rice (toast, boiled, or stir-fried), and fried batter. The Spearman’s
correlation coefficients for energy-adjusted dietary acrylamide intake between DRs and FFQ were 0.48
and 0.42 in Cohort I and 0.37 and 0.34 in Cohort II in men and women, respectively [26].
2.3. Follow-Up and Identification of Cancer Cases
The subjects were followed from the date of the 5-year follow-up survey until 31 December 2013.
The annual residential status was confirmed using the residential registry. During the study period,
5022 subjects (5.9%) moved out of the study area, and 13,756 subjects (16.1%) died.
Lung cancer cases were identified from major local hospitals by data linkage with population-based
cancer registries. Death certificates were used as a supplementary source of information. All lung
cancer cases were defined according to the International Classification of Diseases for Oncology,
Third Edition, code C34. At the end of the follow-up period, 1187 lung cancer cases were newly
identified in men. Of these, there were 379 adenocarcinomas (M8140, 8211, 8230, 8240, 8246, 8250,
8252, 8254, 8255, 8260, 8310), 323 squamous cell carcinomas (M8070, 8071, 8075, 8560), 140 small-cell
lung carcinomas (M8041, 8045), and 345 others and unclassified cases. A total of 485 cases were newly
identified in women. Of these, there were 358 adenocarcinomas (M8140, 8211, 8230, 8250, 8252, 8253,
8254, 8255, 8260) and 127 others and unclassified cases.
2.4. Statistical Analysis
Analyses in men and women were conducted separately. Accumulated person-years for each
subject were estimated from the start of the 5-year follow-up survey to the date of diagnosis of lung
cancer, date of death from any cause, date of relocation from the study area, or end of follow-up
(31 December 2013), whichever came first. The mean follow-up periods were 14.3 years in men and
15.4 years in women.
The residual method was applied to adjust acrylamide intake using energy intake. Subjects were
divided into quartiles (Q1, Q2, Q3, and Q4 groups) based on energy-adjusted acrylamide intake.
We used Cox proportional hazards models to estimate the hazard ratios (HRs) and 95% confidence
intervals (CIs) of the incidence of lung cancer according to quartiles of energy-adjusted dietary
acrylamide intake, with Q1 as the reference group. Trends were measured by assigning ordinal
values to quartiles of energy-adjusted acrylamide intake. The characteristics of dietary and nondietary
Nutrients 2020, 12, 2417 4 of 13
variables between quartiles Q1, Q2, Q3, and Q4 were compared using the Kruskal–Wallis test or
chi-squared test as appropriate.
The multivariable model was adjusted for age (5-year age intervals), areas (nine public health
center areas), smoking status (never, former, current, or missing), pack-years (<20, 20 to <30, 30 to
<40, 40 to <50, ≥50, or missing), body mass index (14 to <19, 19 to <21, 21 to <23, 23 to <25, 25 to <27,
27 to <30, or 30–40 kg/m2 or missing), physical activity (continuous), family history of lung cancer
(yes or no), alcohol intake (<150 or ≥150 g/week), and energy-adjusted consumption of vegetables and
fruits (continuous). In a sensitivity analysis, we excluded 150 men and 45 women with lung cancer
diagnosed in the first 3 years of follow-up.
Furthermore, the level of acrylamide hemoglobin adducts, a biomarker for exposure to acrylamide,
is 4 times higher in smokers than in nonsmokers [37]. To elucidate the interaction effect, we performed
subgroup analyses for never, former, and current smokers among men. Because 88% of women did
not smoke, a subgroup analysis was conducted only for nonsmokers. All p-values were two-sided,
with significance set at a p-value < 0.05. All statistical analyses were performed using Stata version 15.0
(Stata Corp., College Station, TX, USA).
3. Results
After the exclusion of ineligible participants, a total of 85,303 subjects (39,982 men and
45,321 women) were included in the current study (Figure 1).
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3.1. Analysis of Characteristics
Table 1 shows the characteristics of the study population based on acrylamide intake. The mean
(standard deviation) daily acrylamide intakes were 6.8 (3.9) µg/day in men and 7.0 (3.7) µg/day in
women. The main contributors to total acrylamide intake were coffee (men, 32.0%; women, 23.6%),
green tea (men, 20.2%; women, 22.8%), potatoes and starches (men, 10.4%; women, 12.8%), biscuits
and cookies (men, 8.0%; women, 12.8%), and vegetables (men, 9.9%; women, 11.5%). Relative to
the lowest acrylamide consumption group (Q1), the food and beverage consumption of the highest
acrylamide consumption group (Q4) comprised more coffee, green tea, vegetables, potatoes and
starches, and biscuits and cookies but less meat, fish, and alcohol. Furthermore, compared with the Q1
group, the Q4 group consisted of younger subjects, a greater proportion of current smokers both in
men and women, and a higher pack-years only in men.
3.2. Association between Dietary Acrylamide Intake and Lung Cancer Risk
Table 2 presents the associations between daily acrylamide intake and lung cancer in men.
No association was observed between daily acrylamide intake and lung cancer overall (p for trend = 0.12).
The HR of lung cancer for 10-µg/day increment of acrylamide intake was 1.01 (95% CI, 0.99–1.02).
The results of the sensitivity analysis were similar to those of the overall analysis. For never-smokers,
there were decreased HRs in the Q2, Q3, and Q4 groups, but the 95% CIs were wide. Meanwhile,
no evidence of a decreased risk of lung cancer (HR, 0.98; 95% CI, 0.93–1.02) was observed when
acrylamide intake was treated as a continuous variable. For former and current smokers, acrylamide
was not significantly related to an increased risk of lung cancer. In addition, no associations were
observed in the analysis of any histological subtype of lung cancer.
Table 3 shows the results of daily acrylamide intake and risk of lung cancer in women. Acrylamide
intake was not associated with lung cancer risk by increasing acrylamide intake both in the overall
analysis (p for trend = 0.86) and sensitivity analysis (p for trend = 0.86). For never-smokers, there were
increased HRs in the Q2 and Q3 groups, but the results were not significant. When acrylamide
intake was considered a continuous variable, the HR was 0.98 (95% CI, 0.95–1.01). In addition, a null
association was also observed in the analysis of adenocarcinoma of lung cancer. Limited by the small
number of former and current smokers and other histological subtypes of lung cancer, further subgroup
analysis was not performed.
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Table 1. Characteristics of participants (n = 85,303) in the lung cancer analysis.
Characteristics
Quartiles of Energy-Adjusted Acrylamide Intake
Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-Value 1
Men
Number of participants 9996 9995 9996 9995
Dietary variables
Acrylamide intake
Range, µg/day 0.0–4.1 4.1–5.9 5.9–8.6 8.6–54.3
Mean and SD, µg /day 2.9 (0.8) 5.0 (0.5) 7.1 (0.8) 12.1 (3.7)
Mean and SD, µg kg body weight−1·day−1 0.05 (0.04) 0.08 (0.07) 0.11 (0.10) 0.19 (0.24)
Coffee, g/day 36.6 (52.0) 91.5 (88.0) 167.1 (141.3) 397.8 (350.1) <0.001
Green tea, g/day 265.1 (301.3) 430.0 (403.2) 524.6 (442.2) 750.9 (706.8) <0.001
Potatoes and starches, g/day 8.0 (8.0) 13.6 (12.2) 17.2 (15.9) 18.9 (23.6) <0.001
Biscuits and cookies, g/day 0.5 (0.9) 1.1 (1.6) 1.9 (2.8) 4.1 (7.7) <0.001
Vegetables, g/day 159.0 (109.8) 191.9 (116.9) 208.1 (128.4) 208.4 (138.4) <0.001
Fruit, g/day 141.3 (139.6) 174.2 (142.4) 184.8 (147.0) 180.7 (150.3) <0.001
Meat, g/day 60.9 (47.4) 61.0 (40.0) 61.3 (38.7) 60.7 (38.0) <0.001
Fish, g/day 87.5 (60.8) 90.2 (52.2) 90.3 (51.8) 84.8 (50.8) <0.001
Alcohol intake, g/day 280.1 (285.3) 221.1 (240.0) 185.4 (221.1) 134.1 (188.2) <0.001
Total energy intake, kcal/day 2152.6 (655.4) 2168.1 (640.0) 2187.2 (640.1) 2151.5 (653.7) <0.001
Nondietary variables
Age at 5-year follow-up study, year 57.4 (7.4) 57.1 (7.8) 56.8 (8.0) 56.0 (8.1) <0.001
Body mass index, kg/m2 23.6 (2.9) 23.7 (2.9) 23.6 (2.8) 23.5 (2.9) <0.001
Smoking status, %
Never 35.9 36.4 34.0 28.2
<0.001
Former 18.4 19.1 18.5 16.3
Current 42.9 42.0 45.1 53.4
Missing 2.9 2.5 2.5 2.2
Pack-years, for former and current smokers 35.5 (25.9) 35.3 (19.4) 36.5 (23.5) 39.4 (21.2) <0.001
Physical activity (METs) 36.8 (10.5) 37.8 (10.2) 37.8 (10.1) 37.5 (10.1) <0.001
Women
Number of participants 11,331 11,330 11,330 11,330
Dietary variables
Acrylamide intake
Range, µg/day 0–4.4 4.4–6.2 6.2–8.7 8.7–69.9
Mean and SD, µg/day 3.25 (0.9) 5.3 (0.5) 7.35 (0.7) 11.96 (3.3)
Mean and SD, µg kg body weight−1·day−1 0.06 (0.1) 0.10 (0.1) 0.14 (0.1) 0.23 (0.2)
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Table 1. Cont.
Characteristics
Quartiles of Energy-Adjusted Acrylamide Intake
Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-Value 1
Women
Coffee, g/day 28.7 (43.5) 68.73 (72.3) 118.28 (112.4) 251.39 (260.0) <0.001
Green tea, g/day 301.88 (325.5) 486.27 (412.7) 589.34 (454.5) 869.41 (759.2) <0.001
Potatoes and starches, g/day 10.8 (9.2) 17.55 (13.6) 20.73 (17.0) 22.86 (26.0) <0.001
Biscuits and cookies, g/day 0.95 (1.2) 1.84 (2.0) 3.08 (3.4) 6.33 (8.9) <0.001
Vegetables, g/day 196.95 (122.9) 224.88 (120.3) 235.16 (128.5) 237.11 (139.3) <0.001
Fruit, g/day 215.79 (173.6) 237.51 (161.1) 240.17 (159.6) 231.46 (168.1) <0.001
Meat, g/day 57.06 (43.1) 53.95 (35.1) 52.63 (33.8) 51.67 (33.6) <0.001
Fish, g/day 85.78 (55.4) 86.49 (46.4) 83.5 (45.6) 78.83 (44.3) <0.001
Alcohol intake, g/day 16.17 (84.1) 12.43 (57.2) 12.45 (56.7) 12.43 (51.1) <0.001
Total energy intake, kcal/day 1834.96 (587.2) 1858.17 (551.6) 1883.34 (561.4) 1838.6 (567.8) <0.001
Nondietary variables
Age at 5-year follow-up study, years 58.67 (7.6) 57.77 (7.9) 56.95 (8.0) 55.58 (8.0) <0.001
Body mass index, kg/m2 23.7 (3.3) 23.6 (3.2) 23.48 (3.2) 23.42 (3.2) <0.001
Smoking status, %
Never 87.63 88.72 88.57 85.1
<0.001
Former 0.88 0.94 0.9 1.29
Current 4.22 4.19 4.58 7.62
Missing 7.27 6.15 5.95 5.99
Pack-years, for former and current smokers 22.1 (18.5) 20.2 (14.8) 19.3 (15.1) 21.4 (14.2) <0.001
Physical activity (METs) 35.94 (9.4) 37.22 (9.0) 37.6 (8.9) 37.68 (9.0) <0.001
Values are mean ± SD or percentages. 1 Kruskal–Wallis test for continuous variables and chi-squared test for categorical variables.
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Table 2. Hazard ratios (95% confidence intervals) for lung cancer in men according to quartiles of acrylamide intake.
Quartiles of Energy-Adjusted Acrylamide Intake
10 (µg) Quartile 1 (lowest) Quartile 2 Quartile 3 Quartile 4 (Highest)
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) p forTrend
Overall lung cancer
All men
Number of subjects 39,982 9996 9995 9996 9995
No. of cases/no. of person-years 1187/569,928 278/140,842 264/142,903 287/143,243 358/142,940
Multivariable model a 1 1.01 (0.99–1.02) 1.00 (Reference) 0.96 (0.81–1.14) 1.00 (0.85–1.19) 1.13 (0.95–1.33) 0.12
Multivariable model a (excluding cases <3 years) 1.01 (0.98–1.01) 1.00 (Reference) 0.96 (0.80–1.15) 1.00 (0.83–1.20) 1.12 (0.94–1.34) 0.16
Never-smokers
Number of subjects 13,430 3584 3633 3396 2817
No. of cases/no. of person-years 156/198,485 44/52,988 38/53,783 42/50,238 32/41,475
Multivariable model b2 0.98 (0.93–1.02) 1.00 (Reference) 0.78 (0.50–1.21) 0.92 (0.59–1.43) 0.89 (0.56–1.44) 0.82
Former smoker
Number of subjects 7225 1837 1913 1847 1628
No. of cases/no. of person-years 192/99,827 46/25,158 39/26,520 57/25,543 50/22,605
Multivariable model c3 1.02 (0.99–1.05) 1.00 (Reference) 0.82 (0.54–1.27) 1.23 (0.82–1.83) 1.18 (0.77–1.79) 0.19
Current smoker
Number of subjects 18,321 4283 4198 4507 5333
No. of cases/no. of person-years 809/258,949 181/59,080 179/59,408 182/64,280 267/76,181
Multivariable model c 1.01 (0.99–1.03) 1.00 (Reference) 1.03 (0.83–1.23) 0.97 (0.78–1.19) 1.13 (0.92–1.38) 0.30
Adenocarcinoma
No. of cases/no. of person-years 379/569,928 95/140,842 91/142,903 82/143,243 111/142,940
Multivariable model a 1.01 (0.99–1.03) 1.00 (Reference) 0.94 (0.70–1.26) 0.83 (0.61–1.13) 1.05 (0.79–1.41) 0.87
Squamous cell lung carcinoma
No. of cases/no. of person-years 323/569,928 83/140,842 59/142,903 80/143,243 101/142,940
Multivariable model a 1.01 (0.99–1.03) 1.00 (Reference) 0.71 (0.50–1.01) 0.91 (0.66–1.25) 0.98 (0.72–1.35) 0.69
Small-cell lung carcinoma
No. of cases/no. of person-years 140/569,928 34/140,842 30/142,903 36/143,243 40/142,940
Multivariable model a 1.00 (0.96–1.04) 1.00 (Reference) 0.94 (0.57–1.55) 1.11 (0.68–1.79) 1.11 (0.68–1.81) 0.55
Abbreviations: HR = hazard ratio; 95% CI = 95% confidence interval. 1 Multivariable model a adjusted for age (5-year age intervals), areas, smoking status (never, former, current,
or missing), pack-years (<20, 20 to <30, 30 to <40, 40 to <50, ≥50, or missing), body mass index (14 to <19, 19 to <21, 21 to <23, 23 to <25, 25 to <27, 27 to <30, or 30–40 kg/m2 or missing),
physical activity (continuous), family history of lung cancer (yes or no), alcohol intake (<150 or ≥150 g/week), and energy-adjusted consumption of vegetables and fruits (continuous).
2 Multivariable model b adjusted for age (5-year age intervals), areas, body mass index (14 to <19, 19 to <21, 21 to <23, 23 to <25, 25 to <27, 27 to <30, or 30–40 kg/m2 or missing),
physical activity (continuous), family history of lung cancer (yes or no), alcohol intake (<150 or ≥150 g/week), and energy-adjusted consumption of vegetables and fruits (continuous).
3 Multivariable model c adjusted for age (5-year age intervals), areas, pack-years (<20, 20 to <30, 30 to <40, 40 to <50, ≥50, or missing), body mass index (14 to <19, 19 to <21, 21 to <23, 23 to
<25, 25 to <27, 27 to <30, or 30–40 kg/m2 or missing), physical activity (continuous), family history of lung cancer (yes or no), alcohol intake (<150 or ≥150 g/week), and energy-adjusted
consumption of vegetables and fruits (continuous).
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Table 3. Hazard ratios (95% confidence intervals) for lung cancer in women according to quartiles of acrylamide intake.
Quartiles of Energy-Adjusted Acrylamide Intake
10 (µg) Quartile 1 (lowest) Quartile 2 Quartile 3 Quartile 4 (Highest)
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) p forTrend
Overall Lung Cancer
All women
Number of subjects 45,321 11,331 11,330 11,330 11,330
No. of cases/no. of person-years 485/698,086 113/174,917 135/174,528 129/174,527 108/174,114
Multivariable model a 1 0.98 (0.95–1.02) 1.00 (Reference) 1.21 (0.94–1.56) 1.19 (0.92–1.54) 1.03 (0.78–1.36) 0.86
Multivariable model a (excluding cases <3 years) 0.97 (0.95–1.01) 1.00 (Reference) 1.20 (0.92–1.56) 1.14 (0.87–1.49) 0.99 (0.74–1.32) 0.86
Never-smokers
Number of subjects 39,658 9929 10,052 10,035 9642
No. of cases/no. of person-years 406/618,469 94/155,579 118/156,467 117/156,315 77/150,108
Multivariable model b 2 0.98 (0.95–1.01) 1.00 (Reference) 1.28 (0.97–1.68) 1.30 (0.98–1.72) 0.98 (0.71–1.33) 0.98
Adenocarcinoma
No. of cases/no. of person-years 358/698,086 79/174,917 96/174,528 104/174,527 79/174,114
Multivariable model a 0.97 (0.94–1.01) 1.00 (Reference) 1.21 (0.90–1.64) 1.34 (0.98–1.80) 1.06 (0.77–1.47) 0.57
Abbreviations: HR = hazard ratio; 95% CI = 95% confidence interval. 1 Multivariable model a adjusted for age (5-year age intervals), areas, smoking status (never, former, current,
or missing), pack-years (<20, 20 to <30, 30 to <40, 40 to <50, ≥50, or missing), body mass index (14 to <19, 19 to <21, 21 to <23, 23 to <25, 25 to <27, 27 to <30, or 30–40 kg/m2 or missing),
physical activity (continuous), family history of lung cancer (yes or no), alcohol intake (<150 or ≥150 g/week), and energy-adjusted consumption of vegetables and fruits (continuous).
2Multivariable model b adjusted for age (5-year age intervals), areas, body mass index (14 to <19, 19 to <21, 21 – <23, 23 to <25, 25 to <27, 27 to <30, or 30–40 kg/m2 or missing), physical
activity (continuous), family history of lung cancer (yes or no), alcohol intake (<150 or ≥150 g/week), and energy-adjusted consumption of vegetables and fruits (continuous).
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4. Discussion
Based on this large-scale prospective cohort study, we did not find any association between dietary
acrylamide intake and overall risk of lung cancer in both men and women.
One previous study among Finnish male smokers showed a positive association between dietary
acrylamide intake and risk of lung cancer with a multivariable relative risk of 1.18 (95% CI, 1.01–1.38)
in the highest vs. lowest level [20]. In our study, the HR for high vs. low level of acrylamide intake
was 1.13 (95% CI, 0.95–1.33). One reason for our null association could be that Japanese men had much
lower acrylamide intake relative to Finnish men. The median acrylamide intakes of the lowest level
were 21.9 and 3.0 µg/day for Finish and Japanese male smokers, and the median acrylamide intakes of
the highest level were 55.7 and 11.2 µg/day, respectively.
Another study in the Netherlands reported that acrylamide intake was inversely associated
with lung cancer risk in women but was not associated in men. The overall risk of lung cancer has
statistically significantly decreased with increased acrylamide intake in women. The HRs were 0.82
(95% CI, 0.69–0.96) for a 10-µg/day increment of acrylamide intake and 0.45 (95% CI, 0.27–0.76; p for
trend = 0.01) for the highest vs. lowest quintile of acrylamide intake [19]. The authors suggested
that acrylamide may affect the hormonal balance, supported by postmenopausal hormone treatment
associated with decreased lung cancer risk in some studies. In contrast, the results in all men in the
Netherlands were similar to those of our study. For male never-smokers, the risk of lung cancer
in the former study was increased in the second and third tertiles compared to the lowest tertile.
However, in our study, we observed decreased risk across the intake quartiles, although p for trend
was not significant.
The average acrylamide intake was 21.7 µg/day in the Netherlands Cohort Study on Diet and
Cancer and 26.2 µg/day in the European Prospective Investigation into Cancer and Nutrition [38],
with both being much higher than that in our study. Green tea is a specific source of acrylamide
exposure in the Japanese population, contributing substantially to the total exposure. One study in
Japan divided subjects into green tea drinkers and nondrinkers to investigate the relationship between
dietary acrylamide intake and risk of digestive system cancer, but no association was found [18].
To date, three Japanese studies on the relationship between dietary acrylamide intake and cancer
risk have been reported [16–18]. These studies provided evidence that acrylamide intake was not
associated with increased risk of breast, endometrial, ovarian, esophageal, gastric, and colorectal
cancer in Japanese individuals. Because of differences in average acrylamide intake and common null
association between acrylamide intake and most cancers, there might be no substantial difference
between Asian and Western populations in sensitivity to acrylamide intake.
Our study has some strengths. This study has a prospective cohort study design. The avoidance
of recall bias in exposure was made by collecting data before the diagnosis of lung cancer. The sample
size of this study was large, with participants selected from the general population. The cumulative
incidence rates of lung cancer among participants from 1995–2013 were similar to that of the general
Japanese population. In addition, the proportion of lung cancer cases ascertained by death certificate
only was 2.6%, proving sufficient quality of the cancer registries in this study.
There are some limitations in the current study. First, acrylamide levels differ widely across
foods, which may contribute to misclassification of dietary acrylamide intake. We used acrylamide
values of foods measured in the 2000s because measured values were not available in the 1990s.
However, foods consumed in the 1990s had a higher proportion of beverages but a lower proportion of
vegetables than those in the 2000s [34]. Acrylamide values measured in the 2000s may not completely
represent foods in the 1990s. Furthermore, FFQ is the only workable way in large-scale epidemiological
studies to determine dietary acrylamide intake over a long period, although estimated acrylamide
intake depends on the question items and options of the questionnaire. The correlation coefficients
of dietary acrylamide intake from the FFQ and 28-day DRs ranged from 0.34 to 0.48 [26]. Second,
passive smoking is a risk factor for lung cancer in Japanese women [39]. Since the 5-year follow-up
survey did not include related information, we could not further adjust for this risk factor in the model.
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Finally, unknown confounders may have affected the results, although we had adjusted for possible
confounders in the analysis.
5. Conclusions
This study did not provide evidence that dietary acrylamide intake has a positive association with
lung cancer in the Japanese population, in both men and women.
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